Current Issue Vol. 43, No. 1
Immunodeficiency-associated lymphoproliferative disorders and lymphoid neoplasms in post-COVID-19 pandemic era
Authors :Gluzman D.F. Zavelevich M.P.* Philchenkov A.A. Koval S.V.... Date: 2021-03-26 / Views: 194
Authors :Gluzman D.F. Zavelevich M.P.* Philchenkov A.A. Koval S.V.... Date: 2021-03-26 / Views: 194
Experience and prospects for the use of off-label drugs in oncology
Authors :Drogovoz S.M. Starikov V.I. Ivantsyk L.B. Shchokina K.G.* Date: 2021-03-25 / Views: 208
Authors :Drogovoz S.M. Starikov V.I. Ivantsyk L.B. Shchokina K.G.* Date: 2021-03-25 / Views: 208
Application of gold and silver nanoparticles for selective assay of spermine in mixture with spermidineAuthors :Yanish Yu.V.* Zaletok S.P. Vityuk N.V. Mukha Yu.P. Date: 2021-03-25 / Views: 260
Ornithine decarboxylase activity in prostate cancerAuthors :Samoylenko О.А. Stakhovsky E.O. Vitruk Y.V. Shlyakhovenko V.O.* Date: 2021-03-30 / Views: 158
Experience with the use of HIPEC in advanced serous ovarian cancer after complete and optimal cytoreductionAuthors :Tsip N.P.* Kopetskiy V.I. Polentsov Yu.O. Yegorov M.Yu.*... Date: 2021-03-30 / Views: 202
Emergency oncology admissions during COVID-19 pandemic: a major institution experience from Saudi ArabiaAuthors :Elemam O.* Tashkandi E. Abdelkhalek S. Shalaby I.... Date: 2021-03-30 / Views: 183
ROS production by circulating phagocytes and Guerin carcinoma resistance to cisplatin
Authors :Prokhorova I.V.* Gorbach O.I. Yakshibaeva Yu.R. Shliakhtova N.А.... Date: 2021-03-30 / Views: 94
Authors :Prokhorova I.V.* Gorbach O.I. Yakshibaeva Yu.R. Shliakhtova N.А.... Date: 2021-03-30 / Views: 94
A non-coding cancer mutation disrupting an HNF4α binding motif affects an enhancer regulating genes associated to the progression of liver cancerAuthors :Cavalli M.* Diamanti K. Pan G. Dabrowski M.J.... Date: 2021-03-30 / Views: 182
Nuclear localization of BCR and cortactin indicates their potential role in regulation of actin branching in nucleusAuthors :Gurianov D.S.* Antonenko S.V. Telegeev G.D. Date: 2021-03-26 / Views: 181
- Ornithine decarboxylase activity in prostate cancer
Authors :Samoylenko О.А.... [158] - Experience with the use of HIPEC in advanced serous ovarian cancer after...
Authors :Tsip N.P.*... [202] - Emergency oncology admissions during COVID-19 pandemic: a major institution experience from Saudi...
Authors :Elemam O.*... [183]
Journal Facts
Publisher:
Morion LLC
Postal address: 10A Bazhana ave., 02140, Kyiv-140, Ukraine
Phone:+38 (044) 585-9710 (multi-channel)
E-mail: public@morion.kiev.ua
Citation Indexes:
SJR indicator — 0.281 (2020);
H-index — 43 (2020).
Index Copernicus — 118.41 (2019)
- Publication schedule: Printed and posted online quarterly
- Average time from submission to initial decision (full-length manuscripts): 2 months (2020)
- Average time from acceptance to print: 3.0 months (2020)
- Online ISSN: 2312-8852
- Print ISSN: 1812-9269
Journal is indexed in MEDLINE/PubMed/NLM catalog, SCOPUS, EBSCO, EMBASE, Index Copernicus, BIOSIS Previews.